Research map: Indirect comparison of mRNA-1010 versus enhanced influenza vaccines in adults aged 65 years and older during the 2024-2025 US influenza season
Back to the article
Papers in this map
A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity
· Halbert White · 1980 · 26406 citations · Cited by this paper
mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety
· Alexander Domnich · 2026 · Cites this paper
Response to Kirshner et al.: updated cost consequence analyses using requested inputs
· 2026 · Related
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
· Peter C. Austin · 2009 · 6829 citations · Cited by this paper
Clinical burden and healthcare resource utilization after allogeneic hematopoietic stem cell transplant for sickle cell disease or β-thalassemia
· 2026 · Related
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
· Miguel Ángel Hernán · 2016 · 3061 citations · Cited by this paper
Cost-effectiveness of vagus nerve-mediated neuroimmune modulation for the treatment of moderate-to-severe rheumatoid arthritis
· 2026 · Related
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
· Heiner C. Bucher · 1997 · 2086 citations · Cited by this paper
Interpreting per-death productivity estimates in human capital analyses of lung cancer: the role of working-age-restricted denominators
· 2026 · Related
Meta-analysis of individual participant data: rationale, conduct, and reporting
· Richard D Riley · 2010 · 1742 citations · Cited by this paper
An unanchored matching-adjusted indirect comparison of the efficacy of zanubrutinib versus ibrutinib for the treatment of relapsed/refractory mantle-cell lymphoma
· 2026 · Related
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
· Miguel Ángel Hernán · 2016 · 1074 citations · Cited by this paper
Natalizumab is associated with improved relapse outcomes and lower healthcare utilization versus ocrelizumab in treatment-naïve people with multiple sclerosis
· 2026 · Related
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
· Edward A. Belongia · 2016 · 729 citations · Cited by this paper
A system dynamics modelling protocol to evaluate the impact of a health financing mechanism for breast cancer pharmacotherapies in Malaysia
· 2026 · Related
Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head
· Jesse A. Berlin · 2002 · 480 citations · Cited by this paper
The financial impact of surgical interventions for benign prostatic hyperplasia within a single NHS trust
· 2026 · Related
Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal
· David Phillippo · 2017 · 413 citations · Cited by this paper
A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis
· Paul Christopher Lambert · 2002 · 397 citations · Cited by this paper
Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates
· Suzanne E. Ohmit · 2013 · 352 citations · Cited by this paper
Network Meta‐Analysis for Decision Making
· Sofia Dias · 2018 · 351 citations · Cited by this paper
Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season
· Michael L. Jackson · 2017 · 304 citations · Cited by this paper
Influenza Vaccine Effectiveness in the United States During 2012-2013: Variable Protection by Age and Virus Type
· Huong Q. McLean · 2014 · 286 citations · Cited by this paper
2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
· Richard Kent Zimmerman · 2016 · 280 citations · Cited by this paper
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season
· Lisa A. Grohskopf · 2024 · 258 citations · Cited by this paper
Target trial emulation: applying principles of randomised trials to observational studies
· Anthony Matthews · 2022 · 205 citations · Cited by this paper
The immune response to influenza in older humans: beyond immune senescence
· Janet E. McElhaney · 2020 · 172 citations · Cited by this paper
Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes
· Catrin Tudur Smith · 2005 · 171 citations · Cited by this paper
Generalizing Causal Inferences from Individuals in Randomized Trials to All Trial-Eligible Individuals
· Issa J. Dahabreh · 2018 · 163 citations · Cited by this paper
A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults
· Mieke Soens · 2025 · 81 citations · Cited by this paper
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025–26 Influenza Season
· Lisa A. Grohskopf · 2025 · 65 citations · Cited by this paper
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
· Colin A. Russell · 2024 · 58 citations · Cited by this paper
The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis
· Ashleigh A. McGirr · 2019 · 54 citations · Cited by this paper
Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018
· Sankarasubramanian Rajaram · 2020 · 36 citations · Cited by this paper
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review
· Bérengère Macabeo · 2024 · 36 citations · Cited by this paper
Two-stage matching-adjusted indirect comparison
· Remiro-Az\'ocar, Antonio · 2022 · 23 citations · Cited by this paper
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
· Isabel Leroux‐Roels · 2026 · 22 citations · Cited by this paper
Better, Faster, Stronger: mRNA Vaccines Show Promise for Influenza Vaccination in Older Adults
· Jenna M. Bartley · 2021 · 21 citations · Cited by this paper
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
· Michele A. Kohli · 2021 · 21 citations · Cited by this paper
Source: OpenAlex (CC0)